Citation Impact
Citing Papers
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia
2015
Primary care physicians’ attitudes to the adoption of electronic medical records: a systematic review and evidence synthesis using the clinical adoption framework
2018 Standout
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
2017
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
2018
Traditional Chinese Medicine for Cardiovascular Disease
2017 Standout
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
2020
ROS in cancer therapy: the bright side of the moon
2020 Standout
Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
2013
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
2016
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials
2016
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing
2019 Standout
Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
2014
Drug repurposing: progress, challenges and recommendations
2018 Standout
DMTO: a realistic ontology for standard diabetes mellitus treatment
2018
Systematic review and meta-analysis of the efficacy and hypoglycemic safety of gliclazide versus other insulinotropic agents
2015
Type 2 diabetes
2017 Standout
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
2017 Standout
Depression and type 2 diabetes: a causal association?
2013
Lipid-modifying effects of adjunctive therapy with curcuminoids–piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial
2014
Recent advancements in biopolymer and metal nanoparticle-based materials in diabetic wound healing management
2018
Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis
2015
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
2016
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
2017
Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
2015
Type 2 diabetes mellitus
2015 Standout
Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey
2013
A comparison study of metformin only therapy and metformin combined with Chinese medicine jianyutangkang therapy in patients with type 2 diabetes: A randomized placebo-controlled double-blind study
2015
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
2017
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert Forum
2017
Mortality risk among sulfonylureas: a systematic review and network meta-analysis
2014
New Insulins and New Aspects in Insulin Delivery
2015
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
2019
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Efficacy and safety of glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: A systematic review and mixed‐treatment comparison analysis
2016
Curcumin: A Review of Its Effects on Human Health
2017 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Prediabetes Deserves More Attention: A Review
2020
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
A Synopsis of the Associations of Oxidative Stress, ROS, and Antioxidants with Diabetes Mellitus
2022
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Is insulin the most effective injectable antihyperglycaemic therapy?
2014
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Targeting orphan G protein‐coupled receptors for the treatment of diabetes and its complications: C‐peptide andGPR 146
2016
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
2016
An intelligent healthcare monitoring framework using wearable sensors and social networking data
2020 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
2019
Novel Agents for the Treatment of Type 2 Diabetes
2014
Diabetic Kidney Disease
2017 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
2016
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice
2017
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial
2015
Tailoring the volatility and stability of oligopeptides
2017 StandoutNobel
Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR)
2014
Urinary tract and genital infections in patients with type 2 diabetes treated with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis of randomized controlled trials
2016
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Electronic medical records: the family practice resident perspective.
2001
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Ronald Goldenberg being referenced
SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis
2016
Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials
2019
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
2018
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study
2018
Screening for Type 1 and Type 2 Diabetes
2013
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
2020
Less Nocturnal Hypoglycemia and Weight Gain with New Insulin Glargine 300 U/mL Compared with 100 U/mL: 1-Year Results in People with T2DM Using Basal Insulin with OADs (EDITION 2)
2014
Use of Glycated Hemoglobin (A1C) in the Diagnosis of Type 2 Diabetes Mellitus in Adults
2011
Pharmacologic Management of Type 2 Diabetes
2013
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
2014
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
2013
Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetes–2015 Interim Update
2015
Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone ( GetGoal ‐P)
2013
Pharmacologic Management of Type 2 Diabetes: 2016 Interim Update
2016
Insulin plus incretin agent combination therapy in type 2 diabetes: a systematic review
2013